Physician profile
Suresh Kumar
NPI 1053456475
$1,309.04
in general payments reported to CMS, 2019-2025
14 companies · $516 in 2025
The $516 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $39.61 · 2021: $47.56 · 2022: $48.39 · 2023: $295 · 2024: $159 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $970.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $236.13 | 2020-2025 | Bridion |
| Cook Medical LLC | $185.15 | 2023 | Zilver Vena, Zilver Ptx |
| Pacira Pharmaceuticals Incorporated | $167.95 | 2019-2025 | Exparel, Iovera |
| Lundbeck LLC | $166.36 | 2025 | Vyepti |
| Edwards Lifesciences Corporation | $145.20 | 2019-2023 | Hemosphere |
| Fisher & Paykel Healthcare INC | $123.93 | 2025 | Fisher & Paykel Healthcare |
| Pulmonx Corporation | $91.69 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.08 | 2019 | |
| Heron Therapeutics, INC. | $30.65 | 2022 | |
| Zyla Life Sciences, INC. | $20.68 | 2020 | |
| Pfizer INC. | $19.99 | 2023 | |
| Merz Pharmaceuticals, LLC | $18.70 | 2024 | Xeomin |
| Currax Pharmaceuticals LLC | $13.37 | 2023 | Onzetra Xsail |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suresh Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.